SMMT 8-K 2026-11-04

Summit Therapeutics Inc. (SMMT) 8-K dated 2026-11-04 — accession 0001599298-26-000088.

Summit Therapeutics Inc. (SMMT) is a biotechnology company listed on US.

SMMT: EX-99.1 3 a2026_prx1105xq32026earn.htm EX-99.1 1 Summit Therapeutics Re…

This 8-K covers: Results of operations (Item 2.02), Bylaws or fiscal year change (Item 5.03), Shareholder vote results (Item 5.07), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported SMMT revenue for 2024-12-31 was $0. Net income was -$221.3M. SMMT currently screens at market cap $11.46B.

Not investment advice. The SMMT SEC hub lists recent forms. The stock page is the research view.